Corvus Pharmaceuticals Inc Strategic Asset Allocation Index
Corvus Pharmaceuticals Inc strategic asset allocation index. Corvus Pharmaceuticals Inc (CRVS) has a Strategic Asset Allocation Index of 6.7% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $15.11 Million) total $15.11 Million, measured against net assets of $225.33 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CRVS equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Corvus Pharmaceuticals Inc (2016–2025)
Strategic asset allocation index of Corvus Pharmaceuticals Inc from 2016 to 2025. This chart shows how Corvus Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 6.7%, representing strategic assets of $15.11 Million against net assets of $225.33 Million USD. Check CRVS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Corvus Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2016–2025)
Corvus Pharmaceuticals Inc strategic asset allocation index by year from 2016 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Corvus Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Corvus Pharmaceuticals Inc (CRVS) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 18.0% | $10.99 Million | $- | $10.99 Million | $61.20 Million | ▼ -20.5 pp |
| 2024 | 38.5% | $12.54 Million | $- | $12.54 Million | $32.57 Million | ▼ -3.2 pp |
| 2023 | 41.7% | $16.12 Million | $- | $16.12 Million | $38.68 Million | ▲ +2.7 pp |
| 2022 | 39.0% | $21.88 Million | $- | $21.88 Million | $56.12 Million | ▼ 0.0 pp |
| 2021 | 39.0% | $37.91 Million | $3.64 Million | $34.27 Million | $97.16 Million | ▼ -16.1 pp |
| 2020 | 55.1% | $39.78 Million | $2.55 Million | $37.23 Million | $72.15 Million | ▲ +49.8 pp |
| 2019 | 5.3% | $3.79 Million | $3.79 Million | $- | $71.11 Million | ▲ +3.4 pp |
| 2018 | 2.0% | $2.18 Million | $2.18 Million | $- | $110.34 Million | ▼ -1.2 pp |
| 2017 | 3.1% | $2.67 Million | $2.67 Million | $- | $84.83 Million | ▲ +0.7 pp |
| 2016 | 2.4% | $3.25 Million | $3.25 Million | $- | $132.80 Million | — |